Motley Fool Australia

ResApp Health (ASX: RAP) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

ResApp Health (ASX: RAP) Latest News

rising medical asx share price represented by woman stretching happily in bed

Here’s why the ResApp (ASX:RAP) share price is climbing 6%

Aaron Teboneras | December 29, 2020 12:20pm

More »

rising medical asx share price represented by woman stretching happily in bed

Why the ResApp (ASX:RAP) share price is edging higher

Aaron Teboneras | November 24, 2020 3:34pm

More »

Why the Resapp (ASX:RAP) share price stormed 5% higher today

Aaron Teboneras | November 9, 2020 4:38pm

More »

falling asx share price represented by girl falling asleep at her computer

Why the ResApp (ASX:RAP) share price is falling 18% lower today

Aaron Teboneras | October 30, 2020 12:45pm

More »

increase in asx medical software share price represented by doctor making excited hands up gesture

Why the ResApp (ASX:RAP) share price is racing higher today

Aaron Teboneras | October 28, 2020 4:59pm

More »

Why the ResApp (ASX:RAP) share price is up almost 20% today

Aaron Teboneras | October 22, 2020 4:47pm

More »

resmed

The ResApp (ASX:RAP) share price is soaring 10% today. Here’s why.

Aaron Teboneras | October 21, 2020 1:06pm

More »

share price down

Why Computershare, Newcrest, Prospa, & ResApp are sinking lower

James Mickleboro | March 11, 2020 2:21pm

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Dec 2020 Michael Stein Issued 500 $45,000
02 Jul 2020 Anthony (Tony) Keating Sell 10 $1,500,000
01 Jul 2020 Anthony (Tony) Keating Exercise 20 $1,375,000
01 Jul 2020 Anthony (Tony) Keating Buy 20 $1,375,000

Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Roger Aston Non-Executive Chairman,Non-Executive Director Jul 2015
Dr Michael Stein Non-Executive Director Apr 2020
Mr Christopher Ntoumenopoulos Non-Executive Director Jan 2015
Dr Anthony (Tony) Keating Chief Executive Officer,Managing Director Jul 2015
Mr Stephen John Hewitt-Dutton Joint Company Secretary Dec 2020
Ms Nicki Farley Company Secretary
Nicki Farley Company Secretary
Stephen John Hewitt-Dutton Joint Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 69,891,549 9.26%
Freeman Road Pty Ltd 40,500,000 5.36%
J P Morgan Nominees Australia Pty Limited 17,600,530 2.33%
Bnp Paribas Nominees Pty Ltd 17,266,887 2.29%
Mr Frank Weng Thong Chew 13,168,000 1.74%
Mr Anthony James Keating 10,000,000 1.32%
Equimetrixs Pty Ltd 8,437,500 1.12%
Narhex Life Sciences Developments Pty Ltd 7,997,005 1.06%
Cem International (Asia) Pty Ltd 7,849,888 1.04%
Mr Yongsheng Peng & Mrs Yuezhen Xie 4,798,502 0.64%
Let Superannuation Pty Ltd 4,444,103 0.59%
Citicorp Nominees Pty Limited 4,436,079 0.59%
Mr Victor John Wilk 4,400,000 0.58%
Mr Trent Antony Goodrick 4,000,000 0.53%
Wilk Holdings Pty Ltd 4,000,000 0.53%
Queensland Forest Industries Pty Ltd 3,806,830 0.50%
Gardmac Pty Ltd 3,681,395 0.49%
Mr Jason Dennis Roberts 3,431,954 0.45%
Dr Geoffrey Waring 3,303,764 0.44%
Sobol Capital Pty Ltd 3,109,375 0.41%
Show more